Use of a GLP-1R Agonist to Treat Opioid Use Disorder

NCT04199728 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Opiate Substitution Treatment
Opioid-Related Disorders

Interventions

DRUG: Liraglutide Pen Injector
DRUG: Placebo

Sponsor

Milton S. Hershey Medical Center

Collaborators

[object Object]
[object Object]